140 related articles for article (PubMed ID: 23992312)
21. Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
Gallier F; Lallemand P; Meurillon M; Jordheim LP; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
PLoS Comput Biol; 2011 Dec; 7(12):e1002295. PubMed ID: 22174667
[TBL] [Abstract][Full Text] [Related]
22. Expression of bovine cytosolic 5'-nucleotidase (cN-II) in yeast: nucleotide pools disturbance and its consequences on growth and homologous recombination.
Allegrini S; Filoni DN; Galli A; Collavoli A; Pesi R; Camici M; Tozzi MG
PLoS One; 2013; 8(5):e63914. PubMed ID: 23691116
[TBL] [Abstract][Full Text] [Related]
23. The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme.
Banditelli S; Baiocchi C; Pesi R; Allegrini S; Turriani M; Ipata PL; Camici M; Tozzi MG
Int J Biochem Cell Biol; 1996; 28(6):711-20. PubMed ID: 19927594
[TBL] [Abstract][Full Text] [Related]
24. The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities.
Pesi R; Turriani M; Allegrini S; Scolozzi C; Camici M; Ipata PL; Tozzi MG
Arch Biochem Biophys; 1994 Jul; 312(1):75-80. PubMed ID: 8031149
[TBL] [Abstract][Full Text] [Related]
25. Active and regulatory sites of cytosolic 5'-nucleotidase.
Pesi R; Allegrini S; Careddu MG; Filoni DN; Camici M; Tozzi MG
FEBS J; 2010 Dec; 277(23):4863-72. PubMed ID: 21029378
[TBL] [Abstract][Full Text] [Related]
26. Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview.
Chiarelli LR; Fermo E; Zanella A; Valentini G
Hematology; 2006 Feb; 11(1):67-72. PubMed ID: 16522554
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship of cytoplasmic 5'-nucleotidase substrate sites.
Skladanowski AC; Hoffmann C; Krass J; Jastorff B; Makarewicz W
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):1001-7. PubMed ID: 8615751
[TBL] [Abstract][Full Text] [Related]
28. Evidence for essential catalytic determinants for human erythrocyte pyrimidine 5'-nucleotidase.
Amici A; Ciccioli K; Naponelli V; Raffaelli N; Magni G
Cell Mol Life Sci; 2005 Jul; 62(14):1613-20. PubMed ID: 15968458
[TBL] [Abstract][Full Text] [Related]
29. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Lachant NA; Zerez CR; Tanaka KR
Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
[TBL] [Abstract][Full Text] [Related]
30. Human erythrocyte pyrimidine 5'-nucleotidase, PN-I.
Amici A; Magni G
Arch Biochem Biophys; 2002 Jan; 397(2):184-90. PubMed ID: 11795870
[TBL] [Abstract][Full Text] [Related]
31. Is the expression of deoxynucleoside kinases and 5'-nucleotidases in animal tissues related to the biological effects of nucleoside analogs?
Eriksson S
Curr Med Chem; 2013; 20(34):4241-8. PubMed ID: 23992317
[TBL] [Abstract][Full Text] [Related]
32. Identification, Heterologous Expression, and Functional Characterization of Bacillus subtilis YutF, a HAD Superfamily 5'-Nucleotidase with Broad Substrate Specificity.
Zakataeva NP; Romanenkov DV; Yusupova YR; Skripnikova VS; Asahara T; Gronskiy SV
PLoS One; 2016; 11(12):e0167580. PubMed ID: 27907199
[TBL] [Abstract][Full Text] [Related]
33. Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides.
Amici A; Emanuelli M; Magni G; Raffaelli N; Ruggieri S
FEBS Lett; 1997 Dec; 419(2-3):263-7. PubMed ID: 9428647
[TBL] [Abstract][Full Text] [Related]
34. Adenosine 3':5'-cyclic monophosphate (cAMP)-inducible pyrimidine 5'-nucleotidase and pyrimidine nucleotide metabolism of chick embryonic erythrocytes.
Dragon S; Hille R; Götz R; Baumann R
Blood; 1998 Apr; 91(8):3052-8. PubMed ID: 9531619
[TBL] [Abstract][Full Text] [Related]
35. A case of hemolytic anemia due to erythrocyte pyrimidine 5'-nucleotidase deficiency.
Ozsoylu S; Gurgey A
Acta Haematol; 1981; 66(1):56-8. PubMed ID: 6270945
[TBL] [Abstract][Full Text] [Related]
36. Purification and regulation of an AMP-specific cytosolic 5'-nucleotidase from dog heart.
Darvish A; Metting PJ
Am J Physiol; 1993 May; 264(5 Pt 2):H1528-34. PubMed ID: 8498566
[TBL] [Abstract][Full Text] [Related]
37. A case of lead intoxication: clinical and biochemical studies.
Miwa S; Ishida Y; Takegawa S; Urata G; Toyoda T
Am J Hematol; 1981; 11(1):99-105. PubMed ID: 6267939
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes.
Wu JZ; Larson G; Walker H; Shim JH; Hong Z
Antimicrob Agents Chemother; 2005 Jun; 49(6):2164-71. PubMed ID: 15917509
[TBL] [Abstract][Full Text] [Related]
39. Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency.
Marinaki AM; Escuredo E; Duley JA; Simmonds HA; Amici A; Naponelli V; Magni G; Seip M; Ben-Bassat I; Harley EH; Thein SL; Rees DC
Blood; 2001 Jun; 97(11):3327-32. PubMed ID: 11369620
[TBL] [Abstract][Full Text] [Related]
40. Crystal structures of human and murine deoxyribonucleotidases: insights into recognition of substrates and nucleotide analogues.
Walldén K; Rinaldo-Matthis A; Ruzzenente B; Rampazzo C; Bianchi V; Nordlund P
Biochemistry; 2007 Dec; 46(48):13809-18. PubMed ID: 17985935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
